In a bid to make Germany a more desirable clinical research location, a new bill has been drawn up that would harmonize rules governing advanced therapies and introduce measures to facilitate decentralized clinical trials (DCTs).
These measures have been welcomed by industry, but another that would introduce standard contractual clauses for agreements between clinical trial sponsors and sites is being treated with more caution, said Adem
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?